{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:09:24Z","timestamp":1762099764475,"version":"build-2065373602"},"reference-count":43,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":521,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2000,8]]},"abstract":"<jats:p>Calmodulin (CaM) has been shown to suppress basal G protein coupling and attenuate agonist\u2010stimulated G protein coupling of the \u03bc\u2010opioid receptor (OP<jats:sub>3<\/jats:sub>) through direct interaction with the third intracellular (i3)\n \nloop of the receptor. Here we have investigated the role of CaM in regulating\n \nchanges in OP<jats:sub>3<\/jats:sub>\u2010G protein coupling during morphine treatment, shown\n \nto result in CaM release from plasma membranes. Basal and agonist\u2010stimulated G\n \nprotein coupling by OP<jats:sub>3<\/jats:sub> was measured before and after morphine\n \npretreatment by incorporation of guanosine\n \n5\u2032\u2010<jats:italic>O<\/jats:italic>\u2010(3\u2010[<jats:sup>35<\/jats:sup>S]thiotriphosphate) into membranes,\n \nobtained from HEK 293 cells transfected with human OP<jats:sub>3<\/jats:sub> cDNA. The\n \nopioid antagonist \u03b2\u2010chlornaltrexamine fully suppressed basal G protein\n \ncoupling of OP<jats:sub>3<\/jats:sub>, providing a direct measure of basal signaling.\n \nPretreatment of the cells with morphine enhanced basal G protein coupling\n \n(sensitization). In contrast, agonist\u2010stimulated coupling was diminished\n \n(desensitization), resulting in a substantially flattened morphine\n \ndose\u2010response curve. To test whether CaM is involved in these changes, we\n \nconstructed OP<jats:sub>3<\/jats:sub>\u2010i3 loop mutants with reduced affinity for CaM\n \n(K273A, R275A, and K273A\/R275A). Basal signaling of these mutant\n \nOP<jats:sub>3<\/jats:sub> receptors was higher than that of the wild\u2010type receptor and,\n \nmoreover, unaffected by morphine pretreatment, whereas desensitization to\n \nagonist stimulation was only slightly attenuated. Therefore,\n \nCaM\u2010OP<jats:sub>3<\/jats:sub> interactions appear to play only a minor role in the\n \ndesensitization of OP<jats:sub>3<\/jats:sub>. In contrast, release of CaM from the plasma\n \nmembrane appears to enhance the inherent basal G protein coupling of\n \nOP<jats:sub>3<\/jats:sub>, thereby resolving the paradox that OP<jats:sub>3<\/jats:sub> displays both desensitization and sensitization during morphine treatment.<\/jats:p>","DOI":"10.1046\/j.1471-4159.2000.0750763.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:46:51Z","timestamp":1047451611000},"page":"763-771","source":"Crossref","is-referenced-by-count":32,"title":["Calmodulin Regulation of Basal and Agonist\u2010Stimulated G Protein Coupling by the \u03bc\u2010Opioid Receptor (OP<sub>3<\/sub>) in Morphine\u2010Pretreated Cell"],"prefix":"10.1111","volume":"75","author":[{"given":"Danxin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher K","family":"Surratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Sad\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_14_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-328X(97)00315-X"},{"key":"e_1_2_14_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1995.65041636.x"},{"key":"e_1_2_14_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1983.tb12652.x"},{"key":"e_1_2_14_4_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.2.782"},{"key":"e_1_2_14_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1997.68041462.x"},{"key":"e_1_2_14_6_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.51.34488"},{"key":"e_1_2_14_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01556-2"},{"key":"e_1_2_14_8_2","first-page":"1651","article-title":"Inverse agonistic effect of ICI\u2010174,864 on the cloned \u03b4\u2010opioid receptor : role   of G protein and adenylyl cyclase activation.","volume":"50","author":"Chiu T.T.","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_14_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/283625a0"},{"key":"e_1_2_14_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)90417-8"},{"key":"e_1_2_14_11_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.56.1.39"},{"key":"e_1_2_14_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5247.363"},{"key":"e_1_2_14_13_2","first-page":"656","article-title":"Protein kinase C activation increases the rate and magnitude of agonist\u2010induced \u03b4\u2010opioid   receptor down\u2010regulation in NG108\u201015 cells.","volume":"42","author":"Gucker S.","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_14_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(90)90228-Q"},{"key":"e_1_2_14_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1997.69041767.x"},{"key":"e_1_2_14_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(92)90060-J"},{"key":"e_1_2_14_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5335.52"},{"key":"e_1_2_14_18_2","first-page":"232","article-title":"Opiates, opioids and addiction.","volume":"1","author":"Kreek M.J.","year":"1996","journal-title":"Mol. Psychiatry"},{"key":"e_1_2_14_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.12.4253"},{"key":"e_1_2_14_20_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00354a041"},{"key":"e_1_2_14_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(86)90008-5"},{"key":"e_1_2_14_22_2","first-page":"389","article-title":"Effects of acute and chronic morphine treatment of calmodulin activity of rat brain.","volume":"22","author":"Nehmad R.","year":"1982","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_14_23_2","first-page":"23","article-title":"Cellular responses to chronic treatment with drugs of abuse.","volume":"7","author":"Nestler E.J.","year":"1993","journal-title":"Crit. Rev. Neurobiol."},{"key":"e_1_2_14_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15169.x"},{"key":"e_1_2_14_25_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.40.24961"},{"key":"e_1_2_14_26_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.39.27610"},{"key":"e_1_2_14_27_2","first-page":"173","article-title":"Agonist\u2010dependent phosphorylation of the \u03b4\u2010opioid   receptor\u2014involvement of G protein\u2010coupled receptor kinases but not   protein kinase C.","volume":"48","author":"Pei G.","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_14_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.20.12402"},{"key":"e_1_2_14_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.8.3092"},{"key":"e_1_2_14_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)91507-B"},{"key":"e_1_2_14_31_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00778a018"},{"key":"e_1_2_14_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199410000-00037"},{"key":"e_1_2_14_33_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.31.22081"},{"key":"e_1_2_14_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0741418.x"},{"key":"e_1_2_14_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1995.64031102.x"},{"key":"e_1_2_14_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)90022-1"},{"key":"e_1_2_14_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(96)00467-X"},{"key":"e_1_2_14_38_2","first-page":"1","article-title":"Simultaneous quantitative assessment of morphine tolerance and physical dependence.","volume":"167","author":"Way E.L.","year":"1969","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_14_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(01)80032-5"},{"key":"e_1_2_14_40_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.52.5.896"},{"key":"e_1_2_14_41_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.46.28869"},{"key":"e_1_2_14_42_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.12.7157"},{"key":"e_1_2_14_43_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.19.11449"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1471-4159.2000.0750763.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1471-4159.2000.0750763.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T10:42:59Z","timestamp":1698576179000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1471-4159.2000.0750763.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["10.1046\/j.1471-4159.2000.0750763.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0750763.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"type":"print","value":"0022-3042"},{"type":"electronic","value":"1471-4159"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}